Osteopenia in transgenic mice with osteoblast-targeted expression of the inducible cAMP early repressor

Bone

Volumn 43, Issue 1, 2008, Pages 101-109

  Chandhoke, Taranpreet K ^a   Huang, Yu Feng ^a   Liu, Fei ^a   Gronowicz, Gloria A ^a   Adams, Douglas J ^a   Harrison, John R ^a   Kream, Barbara E ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

ATF4; Bone; Bone morphometry; CREM; ICER; Osteoblast; Transgenic

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; COMPLEMENTARY DNA; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT MODULATOR; OSTEOCALCIN; PARATHYROID HORMONE; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BASIC LEUCINE ZIPPER MOTIF; BONE DENSITY; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOPENIA; POLYADENYLATION; PROMOTER REGION; RADIOIMMUNOASSAY; REAL TIME POLYMERASE CHAIN REACTION; REPRESSOR GENE; RNA SPLICING; TRANSCRIPTION INITIATION; TRANSGENIC ANIMAL; TRANSLATION INITIATION;

3T3 CELLS; ANIMALS; BONE DENSITY; BONE DISEASES, METABOLIC; CELL DIFFERENTIATION; CELL LINE; CYCLIC AMP RESPONSE ELEMENT MODULATOR; HUMANS; MICE; MICE, TRANSGENIC; OSTEOBLASTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 44949194613     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.03.012     Document Type: Article

References (57)

1. Molina C.A., Foulkes N.S., Lalli E., and Sassone-Corsi P. Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell 75 (1993) 875-886
2. Daniel P.B., Rohrbach L., and Habener J.F. Novel cyclic adenosine 3′,5′-monophosphate (cAMP) response element modulator theta isoforms expressed by two newly identified cAMP-responsive promoters active in the testis. Endocrinology 141 (2000) 3923-3930
3. Stehle J.H., Foulkes N.S., Molina C.A., Simonneaux V., Pevet P., and Sassone-Corsi P. Adrenergic signals direct rhythmic expression of transcriptional repressor CREM in the pineal gland. Nature 365 (1993) 314-320
4. Foulkes N.S., Borrelli E., and Sassone-Corsi P. CREM gene: use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription. Cell 64 (1991) 739-749
5. Foulkes N.S., Mellstrom B., Benusiglio E., and Sassone-Corsi P. Developmental switch of CREM function during spermatogenesis: from antagonist to activator. Nature 355 (1992) 80-84
6. Delmas V., Laoide B.M., Masquilier D., de Groot R.P., Foulkes N.S., and Sassone-Corsi P. Alternative usage of initiation codons in mRNA encoding the cAMP-responsive-element modulator generates regulators with opposite functions. Proc Natl Acad Sci U S A 89 (1992) 4226-4230
7. Gellersen B., Kempf R., and Telgmann R. Human endometrial stromal cells express novel isoforms of the transcriptional modulator CREM and up-regulate ICER in the course of decidualization. Mol Endocrinol 11 (1997) 97-113
8. Molina C.A., Foulkes N.S., Lalli E., and Sassone-Corsi P. Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell 75 (1993) 875-886
9. Stehle J.H., Foulkes N.S., Molina C.A., Simonneaux V., Pevet P., and Sassone-Corsi P. Adrenergic signals direct rythmic expression of transcriptional repressor CREM in the pineal gland. Nature 365 (1993) 314-320
10. Behr R., and Weinbauer G.F. cAMP response element modulator (CREM): an essential factor for spermatogenesis in primates?. Int J Androl 24 (2001) 126-135
11. Takahashi J.S. Circadian rhythms ICER is nicer at night (sir!). Curr Biol 4 (1994) 165-168
12. Bodor J., Spetz A.L., Strominger J.L., and Habener J.F. cAMP inducibility of transcriptional repressor ICER in developing and mature human T lymphocytes. Proc Natl Acad Sci U S A 93 (1996) 3536-3541
13. Bodor J., Bodorova J., and Gress R.E. Suppression of T cell function: a potential role for transcriptional repressor ICER. J Leukoc Biol 67 (2000) 774-779
14. Bodor J., and Habener J.F. Role of transcriptional repressor ICER in cyclic AMP-mediated attenuation of cytokine gene expression in human thymocytes. J Biol Chem 273 (1998) 9544-9551
15. Lamas M., Molina C., Foulkes N.S., Jansen E., and Sassone-Corsi P. Ectopic ICER expression in pituitary corticotroph AtT20 cells: effects on morphology, cell cycle, and hormonal production. Mol Endocrinol 11 (1997) 1425-1434
16. Bodor J., Bodorova J., Bare C., Hodge D.L., Young H.A., and Gress R.E. Differential inducibility of the transcriptional repressor ICER and its role in modulation of Fas ligand expression in T and NK lymphocytes. Eur J Immunol 32 (2002) 203-212
17. Memin E., Yehia G., Razavi R., and Molina C.A. ICER reverses tumorigenesis of rat prostate tumor cells without affecting cell growth. Prostate 53 (2002) 225-231
18. Yehia G., Razavi R., Memin E., Schlotter F., and Molina C.A. The expression of inducible cAMP early repressor (ICER) is altered in prostate cancer cells and reverses the transformed phenotype of the LNCaP prostate tumor cell line. Cancer Res 61 (2001) 6055-6059
19. Yan C., Miller C.L., and Abe J. Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart. Circ Res 100 (2007) 489-501
20. Thonberg H., Lindgren E.M., Nedergaard J., and Cannon B. As the proliferation promoter noradrenaline induces expression of ICER (induced cAMP early repressor) in proliferative brown adipocytes, ICER may not be a universal tumour suppressor. Biochem J 354 (2001) 169-177
21. Tetradis S., Nervina J.M., Nemoto K., and Kream B.E. Parathyroid hormone induces expression of the inducible cAMP early repressor in osteoblastic MC3T3-E1 cells and mouse calvariae. J Bone Miner Res 13 (1998) 1846-1851
22. Nervina J.M., Tetradis S., Huang Y.F., Harrison D., Molina C., and Kream B.E. Expression of inducible cAMP early repressor is coupled to the cAMP-protein kinase A signaling pathway in osteoblasts. Bone 32 (2003) 483-490
23. Kalajzic Z., Liu P., Kalajzic I., Du Z., Braut A., Mina M., et al. Directing the expression of a green fluorescent protein transgene in differentiated osteoblasts: comparison between rat type I collagen and rat osteocalcin promoters. Bone 31 (2002) 654-660
24. Jiang J., Lichtler A.C., Gronowicz G.A., Adams D.J., Clark S.H., Rosen C.J., et al. ransgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling. Bone 39 (2006) 494-504
25. Kalajzic I., Kalajzic Z., Kaliterna M., Gronowicz G., Clark S.H., Lichtler A.C., et al. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res 17 (2002) 15-25
26. Sher L.B., Harrison J.R., Adams D.J., and Kream B.E. Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling. Calcif Tissue Int 79 (2006) 118-125
27. Xiao G., Jiang D., Ge C., Zhao Z., Lai Y., Boules H., et al. Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. J Biol Chem 280 (2005) 30689-30696
28. Smith P.K., Krohn R.I., Hermanson G.T., Mailia A.K., Gartner F.H., Provenzano M.D., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 150 (1985) 76-85
29. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2 (1987) 595-610
30. Sher L.B., Woitge H.W., Adams D.J., Gronowicz G.A., Krozowski Z., Harrison J.R., et al. Transgenic expression of 11beta-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone. Endocrinology 145 (2004) 922-929
31. Gundberg C.M., Clough M.E., and Carpenter T.O. Development and validation of a radioimmunoassay for mouse osteocalcin: paradoxical response in the Hyp mouse. Endocrinology 130 (1992) 1909-1915
32. Yang X., Matsuda K., Bialek P., Jacquot S., Masuoka H.C., Schinke T., et al. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 117 (2004) 387-398
33. Bogdanovic Z., Bedalov A., Krebsbach P.H., Pavlin D., Woody C.O., Clark S.H., et al. Upstream regulatory elements necessary for expression of the rat COL1A1 promoter in transgenic mice. J Bone Miner Res 9 (1994) 285-292
34. Pavlin D., Lichtler A.C., Bedalov A., Kream B.E., Harrison J.R., Thomas H.F., et al. Differential utilization of regulatory domains within the alpha 1(I) collagen promoter in osseous and fibroblastic cells. J Cell Biol 116 (1992) 227-236
35. Burkart A.D., Mukherjee A., and Mayo K.E. Mechanism of repression of the inhibin alpha-subunit gene by inducible 3′,5′-cyclic adenosine monophosphate early repressor. Mol Endocrinol 20 (2006) 584-597
36. Inada A., Hamamoto Y., Tsuura Y., Miyazaki J., Toyokuni S., Ihara Y., et al. Overexpression of inducible cyclic AMP early repressor inhibits transactivation of genes and cell proliferation in pancreatic beta cells. Mol Cell Biol 24 (2004) 2831-2841
37. Bodor J., Feigenbaum L., Bodorova J., Bare C., Reitz Jr. M.S., and Gress R.E. Suppression of T-cell responsiveness by inducible cAMP early repressor (ICER). J Leukoc Biol 69 (2001) 1053-1059
38. Vinson C., Myakishev M., Acharya A., Mir A.A., Moll J.R., and Bonovich M. Classification of human B-ZIP proteins based on dimerization properties. Mol Cell Biol 22 (2002) 6321-6335
39. Montminy M. Transcriptional regulation by cyclic AMP. Annu Rev Biochem 66 (1997) 807-822
40. Yang X., and Karsenty G. ATF4, whose osteoblast accumulation is determined post-translationally, can induce osteoblast-specific gene expression in non-osteoblastic cells. J Biol Chem (2004)
41. Yu V.W., Ambartsoumian G., Verlinden L., Moir J.M., Prud'homme J., Gauthier C., et al. FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice. J Cell Biol 169 (2005) 591-601
42. Grigoriadis A.E., Wang Z.Q., Cecchini M.G., Hofstetter W., Felix R., Fleisch H.A., et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266 (1994) 443-448
43. Grigoriadis A.E., Wang Z.Q., and Wagner E.F. Fos and bone cell development: lessons from a nuclear oncogene. Trends Genet 11 (1995) 436-441
44. Demiralp B., Chen H.L., Koh A.J., Keller E.T., and McCauley L.K. Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos. Endocrinology 143 (2002) 4038-4047
45. Eferl R., Hoebertz A., Schilling A.F., Rath M., Karreth F., Kenner L., et al. The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J 23 (2004) 2789-2799
46. Jochum W., David J.P., Elliott C., Wutz A., Plenk H., Matsuo K., et al. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat Med 6 (2000) 980-984
47. Roschger P., Matsuo K., Misof B.M., Tesch W., Jochum W., Wagner E.F., et al. Normal mineralization and nanostructure of sclerotic bone in mice overexpressing Fra-1. Bone 34 (2004) 776-782
48. Sabatakos G., Sims N.A., Chen J., Aoki K., Kelz M.B., Amling M., et al. Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med 6 (2000) 985-990
49. Kveiborg M., Sabatakos G., Chiusaroli R., Wu M., Philbrick W.M., Horne W.C., et al. DeltaFosB induces osteosclerosis and decreases adipogenesis by two independent cell-autonomous mechanisms. Mol Cell Biol 24 (2004) 2820-2830
50. Gutierrez S., Javed A., Tennant D.K., van Rees M., Montecino M., Stein G.S., et al. CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J Biol Chem 277 (2002) 1316-1323
51. McCarthy T.L., Ji C., Chen Y., Kim K.K., Imagawa M., Ito Y., et al. Runt domain factor (Runx)-dependent effects on CCAAT/enhancer-binding protein delta expression and activity in osteoblasts. J Biol Chem 275 (2000) 21746-21753
52. Vallejo M., Ron D., Miller C.P., and Habener J.F. C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs their binding to cAMP response elements. Proc Natl Acad Sci U S A 90 (1993) 4679-4683
53. Harrison J.R., Huang Y.F., Wilson K.A., Kelly P.L., Adams D.J., Gronowicz G.A., et al. Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice. J Biol Chem 280 (2005) 8117-8124
54. Liu F., Lee S.K., Adams D.J., Gronowicz G.A., and Kream B.E. CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment. Bone 40 (2007) 1135-1143
55. McCarthy T.L., Centrella M., and Canalis E. Cyclic AMP induces insulin-like growth factor I synthesis in osteoblast-enriched cultures. J Biol Chem 265 (1990) 15353-15356
56. Bikle D.D., Sakata T., Leary C., Elalieh H., Ginzinger D., Rosen C.J., et al. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J Bone Miner Res 17 (2002) 1570-1578
57. Kulkarni N.H., Halladay D.L., Miles R.R., Gilbert L.M., Frolik C.A., Galvin R.J., et al. Effects of parathyroid hormone on Wnt signaling pathway in bone. J Cell Biochem 95 (2005) 1178-1190